Efficacy of bacteriophage therapy against vancomycin-resistant Enterococcus feacalis in induced and non-induced diabetic mice

Abstract

The antibiotic resistance of an organism has become an endeavor worldwide. The resistance of bacteria is impacting the immunocompromised patient, especially with diabetic. The bacteriophages are more specific in the elimination of the infections caused by the organism. One of the significant bacteria is Vancomycin-resistant Enterococcus faecalis (VREF), emerging as bioburden rendering infectious diseases in developing countries. We attempted to treat infection of VREF in the induced and non-induced diabetic mice model along with antibiotic and phage treatment. The phage has shown more efficiency than vancomycin antibiotic alone and combined therapy with antibiotic phage treated. The considering phage therapy an alternative source for the treatment in the insulin-dependent diabetic with an infection of bacteria.